Rchr
J-GLOBAL ID：200901047590680146   Update date: Jun. 17, 2024

Kumagai Yuji

クマガイ ユウジ | Kumagai Yuji
Affiliation and department：
Kitasato University

About Kitasato University


Research field  (1)： Pharmacology
Research theme for competitive and other funds  (7)：
  • 2009 - 2011 Effects on metabolism and cognitive functions by hypnotics induced slow wave sleep modulation in healthy young male volunteers
  • 2008 - 2011 Development of probe drugs for the evaluation of the functions of drug transporters in vivo in humans
  • 2008 - 2010 血小板凝集時に放出されるSDFー1による骨髄細胞動員増強作用と臓器線維化の誘導
  • 心拍変動の概日リズム
  • 薬物動態の個人差
Show all
Papers (232)：
  • Michiru OCHIAI, Mika MAEDA, Wakana KUWANO, Mami SUZUKI, Masako ASO, Masahiro KOBAYASHI, Katsuya OTORI, Tomoko HASUNUMA, Yuji KUMAGAI. Research on Information Used in the Development of Pediatric Drugs in Japan: Utilization of Pharmacokinetic Information. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 2024. 55. 1. 3-10
  • Yoshiaki Oda, Yuji Kumagai, Manabu Kanai, Yasuhiro Iwama, Iori Okura, Takeshi Minamida, Yukihiro Yagi, Toru Kurosawa, Benjamin Greener, Ye Zhang, et al. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial. The Lancet. Infectious diseases. 2023
  • Akiko Mutoh, Hitoshi Uehara, Asano Maeda, Akihiro Tokushige, Yasushi Higashiuesato, Mika Maeda, Yuji Kumagai, Shinichiro Ueda. Pharmacokinetics of low doses of colchicine in the leukocytes of Japanese healthy individuals. Translational and clinical pharmacology. 2023. 31. 4. 217-225
  • Yasuyuki Okumura, Takeshi Kimura, Shoichiro Inokuchi, Masahiro Okamoto, Toshio Takano, Masumi Miyake, Yuji Kumagai. Real-World Hepatic Safety of Oral Acetaminophen Versus Loxoprofen/Celecoxib: Using a Nationwide Electronic Medical Record Database. Journal of clinical pharmacology. 2023. 63. 7. 798-806
  • Yoichiro Ogama, Yuji Kumagai, Norio Komatsu, Marito Araki, Nami Masubuchi, Hiroko Akiyoshi, Tadashi Matsuura, Hiromi Kirisako, Akiko Kyoya, Fumiko Nomura, et al. Phase 1 Clinical Trial of PPMX-T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics. Clinical pharmacology in drug development. 2023. 12. 6. 579-587
ｍore...
MISC (161)：
ｍore...
Books (4)：
  • マイクロドーズ臨床試験 理論と実践-新たな創薬開発ツールの活用に向けてー
    (株)じほう 2007
  • くすりとエビデンス
    (株)中山書店 2005
  • GCP不遵守を起こさないプロとコール・SOPの作成
    (株)情報機構 2005
  • 有害事象[領域別]の判断・評価法と当局への対応-判断に苦慮したケーススタディと解決策-
    (株)技術情報協会 2005
Education (4)：
  • - 1989 Oita Medical University
  • - 1989 Oita Medical University Graduate School, Division of Medicine
  • - 1985 Oita Medical University
  • - 1985 Oita Medical University Faculty of Medicine
Professional career (1)：
  • 医学博士
Work history (3)：
  • 2023/04 - 現在 北里研究所病院 研究部 臨床試験アドバイザー
  • 2013 - 2023/04 Kitasato University Hospital Clinical Trial Center Director
  • 2011 - 2023/03 Kitasato University Kitasato Clinical Research Center,Kitasato University School of Medicine Professor,
Committee career (5)：
  • 2016 - 現在 Japanese Society of Clinical Pharmacology and Therapeutics Board member
  • 2010 - 現在 日本アプライド・セラピューティクス学会 評議委員
  • 2009 - 2023/03 日本臨床生理学会 評議員
  • 日本薬理学会 評議員
  • 日本臨床薬理学会 評議員
Awards (1)：
  • 2017/11 - DIA Japan DIA Regional Award - Outstanding Contribution to Health Award
Association Membership(s) (13)：
日本薬学会 ,  日本内分泌学会 ,  日本血液学会 ,  日本心電学会 ,  日本腎臓学会 ,  日本循環器学会 ,  日本高血圧学会 ,  American Society of Clinical Pharmacology and Therapetics ,  日本薬理学会 ,  日本臨床薬理学会 ,  American Society of Clinical Pharmacology and Therapetics ,  The Japanese Pharmacological Society ,  The Japanese Society of Clinical Pharmacology and Therapeutics
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM